Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
small molecule |
| gptkbp:administeredBy |
gptkb:ivacaftor
gptkb:tezacaftor |
| gptkbp:approvedBy |
gptkb:FDA
2019 |
| gptkbp:ATCCode |
gptkb:R07AX31
|
| gptkbp:CASNumber |
2114140-23-2
|
| gptkbp:component |
gptkb:Kaftrio
gptkb:Trikafta |
| gptkbp:developedBy |
gptkb:Vertex_Pharmaceuticals
|
| gptkbp:hasMolecularFormula |
C26H32F2N2O6
|
| https://www.w3.org/2000/01/rdf-schema#label |
elexacaftor
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
CFTR modulator
|
| gptkbp:PubChem_CID |
121439297
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
diarrhea
abdominal pain headache rash upper respiratory tract infection |
| gptkbp:UNII |
6X8QF8YF2V
|
| gptkbp:usedFor |
cystic fibrosis
|
| gptkbp:bfsParent |
gptkb:CFTR_gene
gptkb:CFTR_modulators gptkb:Trikafta |
| gptkbp:bfsLayer |
6
|